Announcements Trials
Browse Landscape

Phase

Phase 3 5Phase 2 2Phase NA 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Plasma cell 1Classical hematology 1

Conditions

Multiple Myeloma 2Precursor Cell Lymphoblastic Leukemia-Lymphoma 1Neoplasms, Plasma Cell 1Motor Activity 1Leukemia 1Fatigue 1Anemia 1

Interventions

Cyclophosphamide 8Peripheral Blood Stem Cell Transplantation 7Busulfan 6Antilymphocyte Serum 6fludarabine phosphate 5Methylprednisolone 4Methotrexate 4Filgrastim 4Cyclosporine 4Psychiatric Rehabilitation 3Whole-Body Irradiation 2Therapeutics 2Tacrolimus 2Radiotherapy 2Mycophenolic Acid 2Melphalan 2Etoposide 2Blood Specimen Collection 2Aprepitant 2fludarabine 1dexamethasone acetate 1dexamethasone 21-phosphate 1Ultraviolet Therapy 1Thiotepa 1Thalidomide 1Tai Ji 1Surveys and Questionnaires 1Restraint, Physical 1Resistance Training 1Polymerase Chain Reaction 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase NA × Neoplasms, Plasma Cell × Epoetin Alfa × Clear all
NCT00400686 2018-02-22

Epoetin Alfa in Treating Anemia in Patients Undergoing Chemotherapy for Multiple Myeloma

The Cleveland Clinic

Phase NA Completed
31 enrolled 5 charts
Classical hematologyPlasma cell

Anemia, Multiple Myeloma, Neoplasms, Plasma Cell

Data powered by HemOnc (CC BY 4.0) Colophon âš¡